Kelly Lawrence W & Associates’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-785
| Closed | -$53.9K | – | 165 |
|
|
2023
Q2 | $53.9K | Hold |
785
| – | – | 0.01% | 100 |
|
|
2023
Q1 | $58.3K | Sell |
785
-200
| -20% | -$16.8K | 0.02% | 103 |
|
|
2022
Q4 | $91.8K | Hold |
985
| – | – | 0.03% | 87 |
|
|
2022
Q3 | $94K | Hold |
985
| – | – | 0.03% | 98 |
|
|
2022
Q2 | $91K | Sell |
985
-1,700
| -63% | -$166K | 0.02% | 101 |
|
|
2022
Q1 | $272K | Hold |
2,685
| – | – | 0.06% | 67 |
|
|
2021
Q4 | $277K | Buy |
+2,685
| New | +$248K | 0.05% | 68 |
|
|
2020
Q2 | – | Sell |
-263
| Closed | -$16K | – | 125 |
|
|
2020
Q1 | $16K | Hold |
263
| – | – | ﹤0.01% | 108 |
|
|
2019
Q4 | $20K | Hold |
263
| – | – | ﹤0.01% | 121 |
|
|
2019
Q3 | $17K | Hold |
263
| – | – | ﹤0.01% | 124 |
|
|
2019
Q2 | $14K | Sell |
263
-668
| -72% | -$36K | ﹤0.01% | 123 |
|
|
2019
Q1 | $50K | Sell |
931
-981
| -51% | -$60.5K | 0.01% | 102 |
|
|
2018
Q4 | $125K | Sell |
1,912
-668
| -26% | -$49.9K | 0.03% | 86 |
|
|
2018
Q3 | $203K | Buy |
2,580
+668
| +35% | +$47.8K | 0.03% | 87 |
|
|
2018
Q2 | $123K | Sell |
1,912
-170
| -8% | -$11.2K | 0.02% | 97 |
|
|
2018
Q1 | $129K | Hold |
2,082
| – | – | 0.02% | 97 |
|
|
2017
Q4 | $151K | Hold |
2,082
| – | – | 0.03% | 92 |
|
|
2017
Q3 | $169K | Hold |
2,082
| – | – | 0.03% | 89 |
|
|
2017
Q2 | $167K | Sell |
2,082
-612
| -23% | -$48.3K | 0.03% | 88 |
|
|
2017
Q1 | $211K | Sell |
2,694
-2,193
| -45% | -$175K | 0.04% | 87 |
|
|
2016
Q4 | $386K | Sell |
4,887
-1,086
| -18% | -$87.9K | 0.09% | 67 |
|
|
2016
Q3 | $531K | Sell |
5,973
-70
| -1% | -$6.61K | 0.11% | 63 |
|
|
2016
Q2 | $579K | Buy |
6,043
+155
| +3% | +$15.4K | 0.13% | 57 |
|
|
2016
Q1 | $611K | Sell |
5,888
-50
| -0.8% | -$4.86K | 0.15% | 51 |
|
|
2015
Q4 | $581K | Sell |
5,938
-2,350
| -28% | -$230K | 0.13% | 54 |
|
|
2015
Q3 | $799K | Sell |
8,288
-1,915
| -19% | -$201K | 0.19% | 50 |
|
|
2015
Q2 | $1.07M | Buy |
10,203
+3,200
| +46% | +$327K | 0.21% | 48 |
|
|
2015
Q1 | $723K | Hold |
7,003
| – | – | 0.16% | 50 |
|
|
2014
Q4 | $674K | Hold |
7,003
| – | – | 0.14% | 55 |
|
|
2014
Q3 | $557K | Sell |
7,003
-25
| -0.4% | -$1.97K | 0.12% | 58 |
|
|
2014
Q2 | $530K | Hold |
7,028
| – | – | 0.11% | 60 |
|
|
2014
Q1 | $526K | Hold |
7,028
| – | – | 0.12% | 59 |
|
|
2013
Q4 | $503K | Hold |
7,028
| – | – | 0.11% | 61 |
|
|
2013
Q3 | $399K | Buy |
7,028
+200
| +3% | +$11.9K | 0.09% | 63 |
|
|
2013
Q2 | $391K | Buy |
+6,828
| New | +$396K | 0.1% | 65 |
|
Other funds holding CVS
Kelly Lawrence W & Associates's CVS Position: Q3 2023 in Review
Kelly Lawrence W & Associates sold out of CVS Health (CVS) in Q3 2023, closing a stake of 785 shares — an estimated $53.9K sold.
Kelly Lawrence W & Associates first reported a position in CVS in Q2 2013 and held it in 35 quarters. The position peaked at $1.07M in Q2 2015. 2,113 funds tracked by Wall St. Rank hold CVS as of Q3 2023.
- Kelly Lawrence W & Associates reported no remaining CVS Health position as of Q3 2023 after selling out during the quarter.
- Kelly Lawrence W & Associates sold 785 CVS Health shares in Q3 2023, an estimated $53.9K.
- Kelly Lawrence W & Associates first reported a position in CVS Health in Q2 2013 and held it in 35 quarters.
- Kelly Lawrence W & Associates's CVS Health position peaked at $1.07M in Q2 2015.
- 2,113 funds tracked by Wall St. Rank held CVS Health as of Q3 2023.
Based on Kelly Lawrence W & Associates's 13F filing for Q3 2023, filed 14 Nov 2023.